Equity (Details)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
Apr. 30, 2025
USD ($)
$ / shares
shares
|
Apr. 29, 2025
USD ($)
$ / shares
shares
|
Mar. 26, 2025
shares
|
Mar. 24, 2025
$ / shares
shares
|
Mar. 21, 2025
USD ($)
shares
|
Mar. 18, 2025
USD ($)
$ / shares
shares
|
Mar. 07, 2025
USD ($)
Shareholders
shares
|
Feb. 02, 2025
shares
|
Jan. 28, 2025
USD ($)
$ / shares
shares
|
Jan. 16, 2025
$ / shares
shares
|
Nov. 01, 2024
shares
|
Aug. 01, 2024
shares
|
Jun. 30, 2024
shares
|
May 03, 2024
USD ($)
shares
|
Mar. 06, 2024
USD ($)
$ / shares
shares
|
Jan. 31, 2024
USD ($)
$ / shares
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Apr. 14, 2025
$ / shares
shares
|
Oct. 25, 2024
shares
|
Jul. 15, 2022
$ / shares
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
285,714,286
|
|
285,714,286
|
|
285,714,286
|
|
|
|
Common stock, par value (in Dollars per share) | $ / shares |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
Common stock, shares issued |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,477,575
|
|
1,477,575
|
|
438,987
|
|
|
|
Common stock, shares outstanding |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,477,575
|
|
1,477,575
|
|
438,987
|
|
|
|
Gross proceeds (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,519,437
|
|
|
|
|
|
Number of shareholders (in Shareholders) | Shareholders |
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares under ATM program |
|
|
|
|
|
12,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commissions and fees (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,855
|
|
|
|
|
|
Proceeds from Debt, Net of Issuance Costs (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,467,582
|
|
|
|
|
|
Recognized in equity (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 772,403
|
43,535
|
772,403
|
|
|
|
|
Recognized in common stock (in Dollars) | $ |
|
|
|
|
|
$ 6,000
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,467,582
|
|
$ 1,467,582
|
|
|
|
|
|
Common stock additional paid in capital (in Dollars) | $ |
|
$ 492,945
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,117,832
|
|
|
|
|
|
|
|
|
|
|
Vested stock options |
|
|
|
|
|
|
|
|
438
|
|
180
|
437
|
437
|
|
438
|
|
|
|
|
1,750
|
|
|
|
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
500,000,000
|
|
500,000,000
|
|
|
|
Preferred stock, par value (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
Exercise price (in Dollars per share) | $ / shares |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,817
|
Contractual floor price (in Dollars per share) | $ / shares |
|
|
$ 3.22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted replacement warrants |
|
|
827,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Replacement warrant aggregate exercise value (in Dollars) | $ |
|
|
$ 2,665,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option value (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,698,058
|
|
|
|
|
|
Exercise price per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,400
|
|
|
|
|
|
|
|
|
|
Exercise day |
|
|
|
|
|
|
|
|
|
|
90 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (42,996)
|
$ 10,484
|
|
|
|
|
Series A Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increased warrants price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 78.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decreased warrants price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
$ 1,938,772
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
829,136
|
|
829,136
|
|
|
|
|
|
Exercise price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.88
|
|
$ 4.88
|
|
|
|
|
|
Warrants outstanding term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years 6 months 29 days
|
|
4 years 6 months 29 days
|
|
4 years 9 months 25 days
|
|
|
|
Replacement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
|
|
|
|
|
138,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 19.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants outstanding term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License # 2 IPR&D Asset [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of common shares |
|
|
|
|
|
|
|
|
438
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Five Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number shares hold by investor |
|
|
165,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
129,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
165,305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of option vesting for remaining period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75.00%
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
138,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of common shares |
|
679
|
|
|
|
|
|
|
|
|
|
|
|
438
|
|
|
|
12,000
|
1,117
|
12,438
|
1,117
|
|
|
|
|
Stock repurchased during period, shares |
|
|
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total consideration (in Dollars) | $ |
|
|
|
|
|
|
|
$ 52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
12,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares under ATM program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
593,194
|
|
593,194
|
|
|
|
|
|
Recognized in equity (in Dollars) | $ |
|
$ 492,945
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,117,832
|
|
|
$ 1
|
$ 1
|
$ 1
|
$ 1
|
|
|
|
|
Recognized in common stock (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 59
|
|
$ 59
|
|
|
|
|
|
Vested stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
437
|
|
|
|
|
|
Stock option value (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14
|
|
|
|
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, par value (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
Office and Administrative [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 36,604
|
79,600
|
|
|
|
|
Discontinued Operations [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,781
|
21,297
|
|
|
|
|
Office and Administration [Member] | Discontinued Operations [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(73,768)
|
5,832
|
|
|
|
|
Research and Development Expense [Member] | Discontinued Operations [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,876
|
2,579
|
|
|
|
|
Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares repurchases |
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares repurchase price per shares (in Dollars per share) | $ / shares |
|
|
|
|
|
|
$ 4,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds (in Dollars) | $ |
|
|
|
|
|
$ 1,484,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares repurchases |
|
|
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
|
|
129,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
|
165,305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Common Stock [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total consideration (in Dollars) | $ |
|
|
|
|
|
|
$ 127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-The-Market Sales Issuance Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,519,437
|
|
|
|
|
|
At-The-Market Sales Issuance Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares under ATM program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
593,194
|
|
|
|
|
|
Exclusive License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,305
|
|
|
Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
Number of shares allocated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,239
|
|
1,239
|
|
|
|
Granted stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57
|
9
|
|
|
|
|
|
|
|
|
Contractual life |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
10 years
|
|
|
|
|
|
|
|
|
Stock option value (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 52,845
|
$ 16,178
|
|
|
|
|
|
|
|
|
Weighted average life of stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years 4 months 28 days
|
|
6 years 10 months 17 days
|
|
|
|
Weighted average exercise price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-Based Payment Arrangement, Tranche One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,750
|
|
|
|
|
|
|
|
|
|
|
Black-Scholes Option Pricing Model [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
Percentage of option vesting for remaining period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75.00%
|
|
|
|
|
|
|
|
|
Black-Scholes Option Pricing Model [Member] | Independent Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
Related Party [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued bonuses (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,372,874
|
|
6,372,874
|
|
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,372,874
|
|
6,372,874
|
|
|
|
|
|
Preferred stock issued as bonus (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 75,000
|
|
$ 75,000
|
|
|
|
|
|
Series B Preferred Stock [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized in equity (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized in common stock (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option value (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Convertible Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non trading shares |
|
|
|
3,036,437
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,336,437
|
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales prices ranging (in Dollars per share) | $ / shares |
|
$ 2.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] | Institutional Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beneficial ownership limitation percentage |
|
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales prices ranging (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.83
|
|
$ 2.83
|
|
|
|
|
|
Maximum [Member] | Institutional Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beneficial ownership limitation percentage |
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|